HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of netilmicin and gentamicin in the treatment of pelvic infections.

Abstract
Seventy-five women admitted with the symptom complex suggestive of pelvic inflammatory disease( PID) were started on a penicillin-aminoglycoside antibiotic regimen. An aminoglycoside, gentamicin or netilmicin (Schering-Plough), was chosen randomly and given parenterally. Forty-two patients received netilmicin and 33 received gentamicin for 5 days. Therapeutic response to the 2 antibiotic regimens was similar. Aminoglycosides have been associated with both nephrotoxicity and ototoxicity. Blood chemistries were studied in all patients. The only manifested toxicity was in 2 patients treated with gentamicin. Endometrial-endocervical cultures were obtained before and after therapy. The microbacteria isolated by standard culture techniques before therapy revealed Neisseria gonorrhoeae in 69% and 51% of the netilmicin and gentamicin groups, respectively; anaerobic organisms were cultured in about 75% of each group.
AuthorsG Schnider, R A Birken, A N Poindexter
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 54 Issue 5 Pg. 554-7 (Nov 1979) ISSN: 0029-7844 [Print] United States
PMID503379 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gentamicins
  • Netilmicin
  • Penicillin G
Topics
  • Acute Disease
  • Adult
  • Drug Therapy, Combination
  • Female
  • Gentamicins (administration & dosage, adverse effects)
  • Humans
  • Netilmicin (administration & dosage, adverse effects)
  • Pelvic Inflammatory Disease (drug therapy)
  • Penicillin G (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: